|
Volumn 12, Issue , 2013, Pages 71-
|
Effects of co-administration of candesartan with pioglitazone on inflammatory parameters in hypertensive patients with type 2 diabetes mellitus: a preliminary report
a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
8-HYDROXYGUANOSINE;
ADIPONECTIN;
ADIPOQ PROTEIN, HUMAN;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
ANTIDIABETIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
C REACTIVE PROTEIN;
CANDESARTAN;
GLYCOSYLATED HEMOGLOBIN;
GUANOSINE;
HEMOGLOBIN A1C PROTEIN, HUMAN;
PIOGLITAZONE;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
SERPINE1 PROTEIN, HUMAN;
TETRAZOLE DERIVATIVE;
VASCULAR CELL ADHESION MOLECULE 1;
ADULT;
AGED;
ANALOGS AND DERIVATIVES;
BLOOD PRESSURE;
COHORT ANALYSIS;
COMPLICATION;
DIABETES MELLITUS, TYPE 2;
DRUG COMBINATION;
FEMALE;
HUMAN;
HYPERTENSION;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
URINE;
ADIPONECTIN;
ADULT;
AGED;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
BENZIMIDAZOLES;
BLOOD PRESSURE;
C-REACTIVE PROTEIN;
COHORT STUDIES;
DIABETES MELLITUS, TYPE 2;
DRUG THERAPY, COMBINATION;
FEMALE;
GUANOSINE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPERTENSION;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
PROSPECTIVE STUDIES;
TETRAZOLES;
THIAZOLIDINEDIONES;
TREATMENT OUTCOME;
VASCULAR CELL ADHESION MOLECULE-1;
|
EID: 84876867000
PISSN: None
EISSN: 14752840
Source Type: Journal
DOI: 10.1186/1475-2840-12-71 Document Type: Article |
Times cited : (8)
|
References (0)
|